Barrow Neurological Institute at Phoenix Children's 2024 Innovation Report
The field of pediatric neuroscience continues to evolve at a remarkable pace, driven by the pursuit of better outcomes and brighter futures for children with neurological and developmental challenges. At the forefront of this progress, our team is dedicated to advancing clinical care, research and education to improve the lives of the children and families we serve.
The 2024 Innovation Report highlights some of the transformative work accomplished over the past year. From groundbreaking clinical programs to cutting-edge research and novel therapeutic approaches, our multidisciplinary teams have worked tirelessly to address some of the most complex neurological disorders in children.
This 2024 Innovation Report offers a small window into what distinguishes Barrow Neurological Institute at Phoenix Children’s as one of the preeminent pediatric neuroscience institutes in the country. Highlights of the past year include:
- Advancing The Care of Children with Cerebrovascular Disease
- Cerebral Vasculopathy in Neurofibromatosis Type 1: An Under-Recognized Problem?
- Hypoglossal Nerve Stimulation: A Novel Tool for Treating Obstructive Sleep Apnea in Children
- The Future of Pediatric Epilepsy Surgery Through a Genetic Lens
This report is a testament to the commitment of our extraordinary clinicians, researchers and staff whose primary goal is to ensure that every child receives the most advanced and compassionate care available. Together, we are shaping the future of pediatric neuroscience – one discovery, one treatment and one success story at a time.
We are honored to share these accomplishments with you and look forward to continuing to push the boundaries of innovation in the year ahead.
Neil Friedman, MBCHB
Director
Barrow Neurological Institute at Phoenix Children’s
Cerebral Vasculopathy in Neurofibromatosis Type 1: An Under-Recognized Problem?
Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by mutations in the NF1 gene, which encodes neurofibromin, a GTPase-activating protein (GAP)-related domain that negatively regulates the Ras/mitogen-activated protein ...
Hypoglossal Nerve Stimulation: A Novel Tool for Treating Obstructive Sleep Apnea in Children
Hypoglossal nerve stimulation is an advanced and emerging therapeutic approach designed to manage obstructive sleep apnea (OSA).
The Future of Pediatric Epilepsy Surgery Through a Genetic Lens
Epilepsy in children continues to be a large-scale medical issue in children, affecting approximately 4 in 1,000 children each year. Epilepsy is defined as having two unprovoked, nonfebrile seizures.